Lovastatin

Hazard statements (CLP)

H317, H351, H361

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

Classified as hazardous in accordance with the criteria of EPA New Zealand Classification under Work Safe New Zealand Classified as hazardous in accordance with the criteria of EPA New Zealand GHS Classification

Physical hazards

Based on available data, the classification criteria are not met

Health hazards

Skin Sensitization Category 1 Carcinogenicity Category 2 Reproductive Toxicity Category 2

Environmental hazards

Based on available data, the classification criteria are not met

Signal word

Warning

Hazard statements

H317 - May cause an allergic skin reaction H351 - Suspected of causing cancer H361 - Suspected of damaging fertility or the unborn child

Prevention

P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P261 - Avoid breathing dust/fume/gas/mist/vapors/spray P272 - Contaminated work clothing should not be allowed out of the workplace P280 - Wear protective gloves/protective clothing/eye protection/face protection

Response

P302 + P352 - IF ON SKIN: Wash with plenty of soap and water P308 + P313 - IF exposed or concerned: Get medical advice/attention P363 - Wash contaminated clothing before reuse

Storage

P403 - Store in a well-ventilated place

Disposal

P501 - Dispose of contents/ container to an approved waste disposal plant

Other hazards which do not result in classification

This product does not contain any known or suspected endocrine disruptors Toxic to terrestrial vertebrates

2.1 Classification of the substance or mixture

Physical hazards Based on available data, the classification criteria are not met Health hazards Skin Sensitization Category 1 Carcinogenicity Category 2 Reproductive Toxicity Category 2 Environmental hazards Based on available data, the classification criteria are not met